IL161448A0 - Method of resolving amlodipine racemate - Google Patents

Method of resolving amlodipine racemate

Info

Publication number
IL161448A0
IL161448A0 IL16144802A IL16144802A IL161448A0 IL 161448 A0 IL161448 A0 IL 161448A0 IL 16144802 A IL16144802 A IL 16144802A IL 16144802 A IL16144802 A IL 16144802A IL 161448 A0 IL161448 A0 IL 161448A0
Authority
IL
Israel
Prior art keywords
resolving
amlodipine racemate
racemate
resolving amlodipine
amlodipine
Prior art date
Application number
IL16144802A
Other languages
English (en)
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of IL161448A0 publication Critical patent/IL161448A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL16144802A 2001-10-24 2002-10-23 Method of resolving amlodipine racemate IL161448A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34625001P 2001-10-24 2001-10-24
PCT/US2002/033894 WO2003035623A1 (en) 2001-10-24 2002-10-23 Method of resolving amlodipine racemate

Publications (1)

Publication Number Publication Date
IL161448A0 true IL161448A0 (en) 2004-09-27

Family

ID=23358583

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16144802A IL161448A0 (en) 2001-10-24 2002-10-23 Method of resolving amlodipine racemate

Country Status (16)

Country Link
US (2) US6822099B2 (cs)
EP (1) EP1448527A1 (cs)
JP (1) JP2005509637A (cs)
KR (1) KR20040062575A (cs)
CN (1) CN1608051A (cs)
BR (1) BR0213505A (cs)
CA (1) CA2466806A1 (cs)
CZ (1) CZ2004531A3 (cs)
HU (1) HUP0401887A3 (cs)
IL (1) IL161448A0 (cs)
MX (1) MXPA04003877A (cs)
NZ (1) NZ532316A (cs)
PL (1) PL369406A1 (cs)
RU (1) RU2004116064A (cs)
WO (1) WO2003035623A1 (cs)
ZA (1) ZA200403052B (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0300444A3 (en) * 2000-04-11 2007-09-28 Sankyo Co Stabilized pharmaceutical compositions containing calcium channel blockers
BE1014922A3 (nl) * 2002-03-01 2004-06-01 Pfizer Ltd Amlodipine als vrije base.
US20030176706A1 (en) * 2002-03-18 2003-09-18 Joshi Rohini Ramesh Process for the preparation of [S(-) amlodipine - L (+)- hemitartarate]
CN1231469C (zh) * 2003-12-05 2005-12-14 石家庄制药集团欧意药业有限公司 一种光学活性氨氯地平的拆分方法
ATE399154T1 (de) * 2004-10-20 2008-07-15 Emcure Pharmaceuticals Ltd Verfahren zur herstellung eines enantiomers von amlodipin in hoher optischer reinheit
JP5124281B2 (ja) * 2004-12-02 2013-01-23 エスケー ケミカルズ カンパニー リミテッド アムロジピンの光学分離方法
KR101152608B1 (ko) 2004-12-02 2012-06-07 에스케이케미칼주식회사 (r,s)-암로디핀으로부터 암로디핀 이성질체의 분리방법
HUP0500570A3 (en) * 2005-06-08 2008-03-28 Richter Gedeon Nyrt Process for the preparation of (s)-(-)-amlodipine
KR101235116B1 (ko) * 2005-10-17 2013-02-20 에스케이케미칼주식회사 광학활성 암로디핀 겐티세이트 염의 제조방법
TW200736245A (en) * 2005-11-29 2007-10-01 Sankyo Co Acid addition salts of optically active dihydropyridine derivatives
TW200806648A (en) * 2005-11-29 2008-02-01 Sankyo Co Acid addition salts of dihydropyridine derivatives
CN100436417C (zh) * 2006-04-11 2008-11-26 石药集团中奇制药技术(石家庄)有限公司 一种光学活性氨氯地平的拆分方法
KR101088488B1 (ko) * 2006-08-30 2011-11-30 주식회사 씨트리 광학활성을 갖는 암로디핀의 제조방법
KR100828883B1 (ko) * 2006-10-27 2008-05-09 씨제이제일제당 (주) 라세믹 암로디핀으로부터 s-(-)-암로디핀의 분리방법
KR100868160B1 (ko) 2007-02-14 2008-11-12 한미약품 주식회사 S-(-)-암로디핀 또는 이의 염의 제조방법 및 이에사용되는 중간체
RU2357781C1 (ru) * 2008-02-06 2009-06-10 Емельяна Зиповна Гильдеева Способ разделения оптических изомеров амлодипина
KR100989970B1 (ko) * 2008-07-01 2010-10-26 미래파인켐 주식회사 (s)-(-)-암로디핀의 분리방법
KR101085169B1 (ko) 2009-03-25 2011-11-18 (주)켐트로스 암로디핀 광학 이성질체의 분리방법
CN101544597B (zh) * 2009-05-15 2012-09-05 北京天衡药物研究院 S-(-)-氨氯地平的制备方法
CN101798280B (zh) * 2010-03-22 2012-05-02 河北师范大学 一种手性拆分消旋体氨氯地平制备s-(-)-氨氯地平和r-(+)-氨氯地平的方法
US10695329B2 (en) 2016-10-07 2020-06-30 Silvergate Pharmaceuticals, Inc. Amlodipine formulations
CA3096101A1 (en) 2018-04-11 2019-10-17 Silvergate Pharmaceuticals, Inc. Amlodipine formulations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714180D0 (en) * 1987-06-17 1987-07-22 Rifar Srl Anhydrous crystalline cefadroxil
WO1988007524A1 (fr) * 1987-03-27 1988-10-06 Byk Gulden Lomberg Chemische Fabrik Gmbh Nouveaux produits intermediaires et procede
US6057344A (en) * 1991-11-26 2000-05-02 Sepracor, Inc. Methods for treating hypertension, and angina using optically pure (-) amlodipine
GB9405833D0 (en) * 1994-03-24 1994-05-11 Pfizer Ltd Separation of the enantiomers of amlodipine
CN1100038C (zh) * 2000-02-21 2003-01-29 张喜田 氨氯地平对映体的拆分
GB0020842D0 (en) * 2000-08-23 2000-10-11 Pfizer Ltd Therapeutic compositions

Also Published As

Publication number Publication date
US6822099B2 (en) 2004-11-23
HUP0401887A3 (en) 2005-05-30
US20030130321A1 (en) 2003-07-10
JP2005509637A (ja) 2005-04-14
BR0213505A (pt) 2004-10-19
RU2004116064A (ru) 2005-11-20
PL369406A1 (en) 2005-04-18
CN1608051A (zh) 2005-04-20
WO2003035623A1 (en) 2003-05-01
ZA200403052B (en) 2005-11-18
CZ2004531A3 (cs) 2004-10-13
MXPA04003877A (es) 2005-02-17
CA2466806A1 (en) 2003-05-01
US20050009887A1 (en) 2005-01-13
KR20040062575A (ko) 2004-07-07
HUP0401887A2 (hu) 2005-01-28
EP1448527A1 (en) 2004-08-25
NZ532316A (en) 2005-10-28

Similar Documents

Publication Publication Date Title
HUP0401887A3 (en) Method of resolving amlodipine racemate
GB0118251D0 (en) Method
PL355161A1 (en) Method of manufacture
GB0122049D0 (en) Method
GB0115243D0 (en) Method
GB0109049D0 (en) Method
GB0103998D0 (en) Method
GB0116453D0 (en) Method
GB0126531D0 (en) Method
GB0114629D0 (en) Method
GB0108349D0 (en) Method
GB0110547D0 (en) Method
GB0101762D0 (en) Method
PL351638A1 (en) Method of obtaining zeolites of a type
GB0116142D0 (en) Method
GB0101763D0 (en) Method
GB0102947D0 (en) Method
GB0110549D0 (en) Selection method
GB0111987D0 (en) Method
GB0125793D0 (en) Method
GB0119269D0 (en) Method
GB2377634B (en) Method of making a spirillicide
GB0104109D0 (en) Method of manufacture
PL351423A1 (en) Method of obtaining a fusible
GB0106634D0 (en) Method of parsing